Most patients notice skin thinning before they have a word for it. Veins appear closer to the surface. Bruises arrive after the smallest contact and stay longer than they used to. The skin on the back of the hand seems to glide more loosely over the underlying tendons. Eyelids become more translucent. These are not separate concerns. They are the same biological story playing out in different zones.
What thinning actually means
Skin is made up of three principal layers: the epidermis at the surface, the dermis beneath it, and the subcutaneous fat layer below that. Thinning refers primarily to changes in the dermis, which holds the structural proteins and supports the vasculature, although epidermal flattening also contributes.
Histological studies of sun-exposed skin describe a consistent pattern with age: the dermal thickness decreases, the rete ridges that interlock the epidermis and dermis flatten, capillary density falls, and the population of active fibroblasts declines. The mechanical consequence is skin that is more fragile, more easily bruised, and slower to repair.
The major contributors
Skin thinning is multifactorial, but the contributing factors are well characterised in the dermatology literature.
- · Chronological ageing, which is associated with gradual reductions in collagen production and fibroblast activity across all skin sites.
- · Cumulative ultraviolet exposure, which is the largest contributor to dermal thinning in sun-exposed areas and produces the characteristic pattern of photoageing.
- · Oestrogen decline at menopause, which is associated with measurable reductions in dermal collagen content in the years immediately following the menopause transition.
- · Long-term use of topical or systemic corticosteroids, which can produce localised or generalised dermal atrophy.
- · Smoking, which is associated with reduced collagen production and altered matrix turnover.
- · Chronic systemic inflammation and certain metabolic conditions, which can influence dermal repair capacity.
Of these, UV exposure is the single largest modifiable contributor in fair-skinned Australian populations. It is also the one most consistently underestimated by patients, because most relevant exposure is accumulated incidentally rather than during obvious sun activities.
Why some areas thin first
Skin thickness varies considerably across the body. The eyelid skin is among the thinnest, with a dermis that may be a fraction of a millimetre thick. The back of the hand, the forearm, the chest and the lower legs are also relatively thin and chronically sun-exposed. The face has a more variable picture, with some regions, such as the upper cheek, that are surprisingly thin and others, such as the chin and forehead, that retain thickness for longer.
When patients describe a sudden awareness that their hands look older than their face, they are often correctly identifying the area that has received the highest cumulative UV dose with the least daily protective attention.
Photoageing and dermal thinning
UV-mediated thinning has been studied extensively. The mechanism involves activation of matrix metalloproteinases, which degrade collagen and elastin, alongside abnormal deposition of damaged elastin known as solar elastosis. Over decades this produces a dermis that is paradoxically thinner in functional structural proteins while being cluttered with non-functional material. Skin that looks crepey, fragile and finely lined at rest is often telling this exact story.
Skin thinning is a slow vote, cast daily, mostly by the sun.
What can be done
The most important interventions are the boring ones, executed for years.
- · Daily broad-spectrum SPF 50+ use, applied generously and reapplied through the day. The 2013 Hughes et al. trial in the Annals of Internal Medicine demonstrated that daily sunscreen use slows visible photoageing.
- · Evidence-based topicals, used appropriately and consistently. Topical retinoids have substantial evidence for supporting epidermal and dermal renewal in photoaged skin.
- · Not smoking. The association between smoking and accelerated facial ageing is well established.
- · Caution with potent topical or systemic corticosteroid use, with regular medical review of any long-term steroid regimen.
In-clinic regenerative approaches, including medical skin needling, bio-remodelling injectables, considered cosmeceutical regimens and selected regulated energy-based devices, aim to support fibroblast activity and dermal quality. They can contribute to a long-term plan, but they layer on top of daily basics rather than replacing them, and they do not perform well in skin that is being photodamaged daily.
Reasonable expectations
Skin thinning can be slowed. It cannot be undone. A face whose dermis was healthier ten years ago will likely never look exactly the same again. What considered care can do is preserve current quality, improve specific concerns where evidence supports an intervention, and avoid acceleration of the natural process. That is enough to look meaningfully different at sixty than the trajectory would otherwise predict.
Building your plan
Whether any treatment is appropriate for you, and how a plan to support skin quality and slow further thinning should be structured, is determined in a one-on-one medical consultation. Your practitioner will examine your skin, review your medical history, discuss your goals and explain the risks of any treatment that may be considered. All cosmetic procedures carry risks and outcomes vary between individuals.
This article is general information and is not medical advice.